KFAS
COLL icon

Keating Financial Advisory Services’s Collegium Pharmaceutical COLL Stock Holding History

Keating Financial Advisory Services’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$905 Hold
25
– – ﹤0.01% 2197
2026
Q1 		$827 Buy
+25
New +$1.06K ﹤0.01% 2140

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Keating Financial Advisory Services's COLL Position: Q2 2026 in Review

Keating Financial Advisory Services held its Collegium Pharmaceutical (COLL) position steady in Q2 2026 at 25 shares worth $905. The position accounts for ﹤0.01% of the portfolio, ranked #2197.

Keating Financial Advisory Services first reported a position in COLL in Q1 2026 and has held it in 2 quarters since. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Keating Financial Advisory Services held 25 shares of Collegium Pharmaceutical worth $905 as of Q2 2026.
  • Keating Financial Advisory Services left its Collegium Pharmaceutical share count unchanged in Q2 2026.
  • Collegium Pharmaceutical made up ﹤0.01% of Keating Financial Advisory Services's portfolio in Q2 2026, its #2197 holding.
  • Keating Financial Advisory Services first reported a position in Collegium Pharmaceutical in Q1 2026 and has held it in 2 quarters since.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Keating Financial Advisory Services's 13F filing for Q2 2026, filed 11 Aug 2026.